| Advice Pool |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Obesity > Should Obesity Be Included As a Risk Factor For Asthma? |
|
Advice Pool - Should Obesity Be Included As a Risk Factor For Asthma?
It is well known that obesity places you at risk of developing problems from such things as diabetes, sleep apnea, cardio According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product vascular disease, stroke and arthritis, but it is now being suggested that asthma should also be added to this list. As ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in he problem of obesity has grown alarmingly in recent years, with about 65 percent of the US population now being classed lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. as either overweight or obese, so too has the problem of asthma. Asthma, which results in recurrent wheezing, coughing an here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe hypersensitivity to allergies, affects about 20 million Americans, including a staggering 9 million children. So could d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro he growing problem of asthma be linked to the rise in obesity? In a recent study, which looked at the records of more th ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc an 330,000 patients in the US, Canada and Europe, it was found that as an individual's body mass index (BMI) passed 25 (t easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi e threshold for being overweight) so his or her chances of developing asthma increased by 50 percent. The study also foun nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically d that as weight continued to increase so too did the risk of developing asthma. The study also showed that this risk se and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ med to be equally distributed between both men and women and that there was no foundation for the previously held belief ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi hat there might be a connection between obesity and asthma in women but not in men. Now if you are overweight and are ex ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a periencing breathing problems you should not immediately leap to the conclusion that you have asthma. Breathing problems dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod an arise with increasing weight as your lung volume is effectively reduced, your chest wall is restricted or indeed for a cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin variety of other reasons. However, if you are experiencing problems you should of course have these checked out by your tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen octor and should not be surprised if this does indeed turn out to be asthma. Asthma is a chronic and incurable, but norm t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel lly controllable, condition which produces an inflammation and narrowing of the airways leading to and from the lungs. Wh ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust at is not clear at this stage however is whether being overweight can actually cause asthma. Further research will be req y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ired but the best guess at the moment is that a substantial proportion of the population is in fact suffering from mild a . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de nd undiagnosed asthma and that an increase in weight aggravates the condition and turns a mild case of asthma into severe elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip asthma. One the other side of coin the good news is that losing weigh could potentially reduce the problem significantly tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:XM Radio for the Best Sounds in the World Wedding Transportation - How to Arrive in Style on a Budget Autism - What Causes Autism and How Can You Prevent It
|